We want to achieve 100% bioavailability of fat-soluble substances.

We bring active substances to their intended destination

We value pharmacodynamics and pharmacokinetics in every step pf the development process.

If you have to administer a very expensive drug and then lose more than three quarters of the active ingredient because the body can not resrob it, then it becomes clear why our patented technology is of interest to pharmaceutical companies. For the same specific effect, our development requires much less active ingredient.